BRIEF-FDA grants fast track designation for aTyr's Resolaris
January 18, 2017 at 08:22 AM EST
* Fda grants fast track designation for aTyr's Resolaris to treat limb girdle muscular dystrophy 2b and removes partial clinical hold for Resolaris
